Error: Could not add to watchlist. X
+ Watchlist

KBC Equity Fund - Pharma

WJFQ:QT
Quotrix Exch
Pending Listing
WJFQ:QT is pending listing
EUR
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
NAV (on -)
-
Total Assets (m EUR) (on 10/31/2017)
277.600
Inception Date
-
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
YOURI AMERIJCKX
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
-
3 Mo Return
-
3 Yr Return
-
5 Yr Return
-

Top Fund Holdings

Name Position Value % of Fund
264.85 k 30.72 m 7.41
413.55 k 23.24 m 5.61
92.19 k 20.61 m 4.97
263.78 k 20.53 m 4.95
291.91 k 17.07 m 4.12
144.04 k 16.40 m 3.96
200.04 k 14.43 m 3.48
58.26 k 12.42 m 3.00
288.60 k 12.30 m 2.97
139.36 k 11.73 m 2.83
Profile
KBC Equity Fund - Pharma is an open-end fund registered in Belgium. The objective of the Fund is income and short to mid-term capital growth. The Fund invests in international stocks of companies that develop and distribute pharmaceutical products and diagnostic drugs and are active in the general healthcare industry with a potential for above average profit.
Address
KBC Asset Management SA
2 Avenue du Port
B-1080 Brussels
Belgium
Phone
32-2-429-5484 Tel